Core B Abstract Core B, Biostatistics & Bioinformatics, will be led by Joseph G. Ibrahim, Ph.D., Joel S. Parker, Ph.D., and Steve Marron, Ph.D. The services of this Core include RNA and DNA sequence data management and analysis, biostatistics, methodological development, and computational infrastructure. The capabilities in this arena at UNC Lineberger and the UNC Gillings School of Public Health are nation-leading. This SPORE Core is the most closely allied with the LCCC Bioinformatics Shared Resources and builds upon its strengths. Core B will consist of investigators from the LCCC Bioinformatics Shared Resource led by Dr. Joel Parker, and the LCCC Biostatistics shared resource lead by Dr. Joe Ibrahim. Core B bioinformatics will be co-led by Joel Parker and Steve Marron, and assisted by Andrew Nobel and Katherine Hoadley. This group has developed and applied data processing and analysis methods that are widely used across the world. Drs. Hoadley and Parker remain key participants in the broader TCGA project having been vital authors on multiple TCGA papers. Senior statisticians Drs. Marron and Nobel began working on genomic analysis in 2001, and have been involved in analytic and methods development ever since. They are closely collaborative with the head of the LCCC Biostatistics Shared Resource, Joe Ibrahim, PhD. He has led this Core for the past 5 years, and biostatistician Dr. Bahjat Qaqish has been involved in this SPORE since the initial 1992 submission. Additional key biostatistics personnel including Naim Rashid, who bring expertise in genomics and ChIP-seq to this Core. The combined experience and ability of the LCCC Biostatistics and Bioinformatics Shared Resources will be available to all projects in this SPORE. The funding for this SPORE Core B is for specific participation in the four projects and to provide advice and analysis capabilities to Career Awardees and those developing pilot projects.

Public Health Relevance

Cancer biology and clinical medicine are increasingly dependent upon the management and analysis of data from sequencing, imaging, and mass spectrometry. These technologies for genomic and proteomic measurement create large, complex, and heterogeneous data that must be integrated with pathological and clinical data. The coordinated analysis of these multiple data types requires a highly sophisticated, facile, and rigorous bioinformatics and statistical infrastructure. Core B brings together computational, informatics, and biostatistics expertise to overcome these challenges and advance our biological understanding and clinical treatment of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA058223-24A1
Application #
9487496
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
24
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Matsunuma, Ryoichi; Chan, Doug W; Kim, Beom-Jun et al. (2018) DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer. Proc Natl Acad Sci U S A 115:E11978-E11987
Panda, Anshuman; de Cubas, Aguirre A; Stein, Mark et al. (2018) Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. JCI Insight 3:
Sharma, Priyanka; López-Tarruella, Sara; García-Saenz, José Angel et al. (2018) Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel. Clin Cancer Res 24:5820-5829
Siegel, Marni B; He, Xiaping; Hoadley, Katherine A et al. (2018) Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J Clin Invest 128:1371-1383
Kumar, Sunil; Lindsay, Daniel; Chen, Q Brent et al. (2018) Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ. NPJ Breast Cancer 4:39
Smith, Christof C; Beckermann, Kathryn E; Bortone, Dante S et al. (2018) Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. J Clin Invest 128:4804-4820
Wheeler, Stephanie B; Spencer, Jennifer C; Pinheiro, Laura C et al. (2018) Financial Impact of Breast Cancer in Black Versus White Women. J Clin Oncol 36:1695-1701
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Tanioka, Maki; Mott, Kevin R; Hollern, Daniel P et al. (2018) Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer. Genome Med 10:86
Tanioka, Maki; Fan, Cheng; Parker, Joel S et al. (2018) Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Clin Cancer Res 24:5292-5304

Showing the most recent 10 out of 598 publications